← Back to headlines
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained
Wall Street analysts have issued new ratings for biopharma companies, with Gilead receiving a 'Buy' recommendation, Amgen a 'Hold', and ORIC gaining a vote of confidence.
10 Mar, 14:38 — 10 Mar, 14:38
Sources
Showing 1 of 1 sources